Figure 3E showed that under the condition of CPG + CD40L stimulation, UM-CLL was significantly more inhibited by 100 and 250 nM of ibrutinib than M-CLL. The gene discussed is CD40LG; the disease is B-cell chronic lymphocytic leukemia.